Tankyrase inhibitor IWR-1, in combination with treatment with salinomycin (SAL), synergistically triggered SAL-induced differentiation of acute promyelocytic leukemia (APL) cells by inhibiting Wnt–β-catenin signaling [134]. Here, TNKS is linked to acute promyelocytic leukemia.